Related Experiment Videos
Sequence of myosin-crossreactive epitopes of streptococcal M protein
Abstract:
Group A streptococcal M proteins contain epitopes that crossreact with sarcolemmal membrane proteins of human myocardium and myosin. In the present study, synthetic peptide copies spanning the entire 197-residue pepsin extracted fragment of type 5 M protein were used to localize the myosin-crossreactive epitopes of the molecule. Peptide 84-116 inhibited by 75% the binding of myosin-crossreactive antibodies evoked by pep M5, as determined by ELISA. Immunoblot inhibition studies confirmed that peptide 84-116 almost totally inhibited the binding of pep M5 antibodies to the heavy chain of human cardiac myosin. None of the remaining synthetic peptides, including peptide 1-35, which contains protective epitopes, inhibited antibodies binding to myosin. Two of three rabbits immunized with peptide 84-116 developed low but significant levels of antibodies crossreactive with myosin. Identification of the primary structures containing tissue-crossreactive as opposed to protective epitopes should not only allow the development of safe and effective M protein vaccines, but may also provide insights into the pathogenesis of rheumatic heart disease.
Insights
Group A streptococcal M proteins have epitopes that cross-react with heart myosin. Researchers identified a specific M protein peptide (84-116) responsible for this cross-reactivity, crucial for understanding rheumatic heart disease.
Area of Science:
- Immunology
- Molecular Biology
- Cardiology
Background:
- Group A streptococcal M proteins possess epitopes that cross-react with human cardiac myosin.
- This cross-reactivity is implicated in the pathogenesis of rheumatic heart disease.
Purpose of the Study:
- To pinpoint the specific epitopes within type 5 M protein responsible for myosin cross-reactivity.
- To differentiate between tissue-crossreactive and protective epitopes.
Main Methods:
- Synthesized peptide copies of the pepsin-extracted fragment of type 5 M protein.
- Utilized Enzyme-Linked Immunosorbent Assay (ELISA) and immunoblot inhibition assays.
- Immunization of rabbits with synthetic peptides.
Main Results:
- Peptide 84-116 significantly inhibited the binding of myosin-crossreactive antibodies to cardiac myosin.
- Peptide 84-116 induced antibodies that cross-reacted with myosin in rabbits.
- Other synthetic peptides, including those with protective epitopes, did not inhibit myosin binding.
Conclusions:
- Peptide 84-116 contains the primary structure responsible for myosin cross-reactivity.
- Distinguishing between cross-reactive and protective epitopes is vital for developing safe M protein vaccines.
- This research offers insights into the mechanisms underlying rheumatic heart disease.